Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 24, 2009 17:04 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Reports On Annual Stockholder Meeting

PHILADELPHIA, June 24, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced that it held its 2009 Annual Meeting of Stockholders. Final voting results will be included in an 8-K to...
June 17, 2009 16:50 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Appoints Robert Dickey IV to the New Position of Senior Vice President

PHILADELPHIA, June 17, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced today the appointment of Robert Dickey IV as Senior Vice President. This is a newly created role at...
June 16, 2009 12:20 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Provides Corporate Update On Various Strategic Initiatives

PHILADELPHIA, June 16, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced that a corporate update on operations has been provided on June 12, 2009 and can be accessed at...
June 12, 2009 09:29 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx's Collaborative Partner in Japan, Biken Corp., Expands Production Capacity for Swine/Avian Flu Vaccines

PHILADELPHIA, June 12, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE AMEX:HEB) announced today that its collaborative influenza vaccine development partner in Japan, Biken, has decided to expand...
June 04, 2009 09:30 ET | Source: Hemispherx Biopharma, Inc.

Japanese National Institute of Infectious Diseases Scientists Identify Hemispherx Biopharma's Drug Technology as the "Most Promising Mucosal Adjuvant for Influenza"

PHILADELPHIA, June 4, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced today that a new peer reviewed publication titled "Development of mucosal adjuvants for intranasal vaccine...
June 01, 2009 09:30 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Presents Influenza Prevention / Treatment Platform at International Conference in Rome under Auspices of Italian Government

PHILADELPHIA, June 1, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced today an invitation, funded entirely by the government of Italy, to present its technology platform for...
May 27, 2009 10:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Announces Payment of 2008 Executive Bonuses

PHILADELPHIA, May 27, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced today that on May 20, 2009, our Board of Directors awarded bonuses to the following executives in...
May 26, 2009 09:15 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Possible Brief Delay in FDA Action On Ampligen(r) New Drug Application

PHILADELPHIA, May 26, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) today announced that the U.S. Food and Drug administration ("FDA") has advised the company that it may require...
May 21, 2009 10:00 ET | Source: Hemispherx Biopharma, Inc.

Japan's Council Awards Innovative Technology Grants for Pandemic Influenza Vaccines Adjuvanted by Hemispherx's Ampligen(r)

PHILADELPHIA, May 21, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced that it has learned that Japan's Council for Science & Technology Policy (CSTP) awarded to the...
May 19, 2009 09:15 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces $16 Million Public Equity Offering

PHILADELPHIA, May 19, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced today that it has agreed to sell up to $16 million in common stock and warrants in a registered offering...